Jiménez Yuste, V. M., Álvarez Roman, M. T., Palomo Bravo, Á., Galmes, B. J., Nieto Hernández, M. d. M., Benítez Hidalgo, O., . . . Mir, R. (2022). Clinical efficacy and safety of fanhdi<sup>®</sup>, a plasma-derived VWF/Factor VIII concentrate, in von willebrand disease in Spain: A retrospective study.
Citación estilo ChicagoJiménez Yuste, Víctor Manuel, et al. Clinical Efficacy and Safety of Fanhdi<sup>®</sup>, a Plasma-derived VWF/Factor VIII Concentrate, in Von Willebrand Disease in Spain: A Retrospective Study. 2022.
Cita MLAJiménez Yuste, Víctor Manuel, et al. Clinical Efficacy and Safety of Fanhdi<sup>®</sup>, a Plasma-derived VWF/Factor VIII Concentrate, in Von Willebrand Disease in Spain: A Retrospective Study. 2022.
Precaución: Estas citas no son 100% exactas.